Triphenylacetate

Names

[ CAS No. ]:
595-91-5

[ Name ]:
Triphenylacetate

[Synonym ]:
MFCD00004185
2,2,2-triphenylacetic acid
Triphenylacetate
Benzeneacetic acid, α,α-diphenyl-, ion(1-)
EINECS 209-873-4

Chemical & Physical Properties

[ Boiling Point ]:
401.4±12.0 °C at 760 mmHg

[ Melting Point ]:
270-273 °C(lit.)

[ Molecular Formula ]:
C₂₀H₁₆O₂

[ Molecular Weight ]:
287.332

[ Flash Point ]:
210.7±16.1 °C

[ Exact Mass ]:
287.107758

[ PSA ]:
37.30000

[ LogP ]:
5.13

[ Vapour Pressure ]:
0.0±1.0 mmHg at 25°C

MSDS

Safety Information

[ Hazard Statements ]:
H413

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xi

[ Safety Phrases ]:
S24/25

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

[ HS Code ]:
2916399090

Synthetic Route

Click to get detail synthetic route

Customs

[ HS Code ]: 2916399090

[ Summary ]:
2916399090 other aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%

Articles

'Organic phase buffers' control biocatalyst activity independent of initial aqueous pH.

Biochim. Biophys. Acta 1206(2) , 161-5, (1994)

Combinations of triisooctylamine with its hydrochloride, or of triphenylacetic acid with its Na+ salt, can function as buffers for use during biocatalysis in organic media. They can control the pH of ...

Inhibition of bilirubin UDPglucuronosyltransferase activity by triphenylacetic acid and related compounds.

Biochim. Biophys. Acta 883(2) , 190-6, (1986)

Bilirubin UDPglucuronosyltransferase of rat or human liver microsomes was inhibited, in vitro, by triphenylacetic acid and by structurally related arylcarboxylic acids. This inhibition appeared to be ...

Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.

J. Med. Chem. 51 , 976-82, (2008)

Sickle cell disease (SCD) is a hereditary condition characterized by deformation of red blood cells (RBCs). This phenomenon is due to the presence of abnormal hemoglobin that polymerizes upon deoxygen...

ethyl triphenylacetate
methyl triphenylacetate
vilanterol triphenylacetate
Vilanterol-d4 (triphenylacetate)
2-hydroxy-1,2,2-triphenylacetate
Rhodium(3+) tris(triphenylacetate)
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
(4-Methyl-tetrahydro-furan-2-yl)-methanol
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
tert-Butyl-DL-alanine
1-(4-Fluorophenyl)-1h-indazol-5-amine
4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide